Log In
Print
BCIQ
Print
Print this Print this
 

Pexa-Vec, pexastimogene devacirepvec (JX-594, TG6006)

Also known as: JX-5940TG6006

  Manage Alerts
Collapse Summary General Information
Company SillaJen Biotherapeutics Inc.
DescriptionRecombinant vaccinia virus (addition of GM-CSF and deletion of thymidine kinase)
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today